Cyclobenzaprine Hydrochloride
Product Images NDC 53002-0524

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 53002-0524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural-formula (Cyclobenzaprine HCl Tablets A071611 1)

Structural-formula (Cyclobenzaprine HCl Tablets A071611 1)
Chemical structure of Cyclobenzaprine Hydrochloride depicted with a bicyclic ring system and its molecular formula C20H21N•HCl with a molecular weight of 311.9.*
FDA Label Image

Label Image (Lbl530020524)

Label Image (Lbl530020524)
Cyclobenzaprine Hydrochloride 5 mg tablets packaging label from RPK Pharmaceuticals, Inc. The label indicates the package contains 30 tablets with directions to take 1 tablet three times a day as needed or as directed. The label includes NDC 53002-0524 and batch, expiration, and barcoding information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.